Country: Amerika Syarikat
Bahasa: Inggeris
Sumber: NLM (National Library of Medicine)
LEVOFLOXACIN (UNII: 6GNT3Y5LMF) (LEVOFLOXACIN ANHYDROUS - UNII:RIX4E89Y14)
Proficient Rx LP
LEVOFLOXACIN
LEVOFLOXACIN ANHYDROUS 500 mg
ORAL
PRESCRIPTION DRUG
To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin tablets, USP and other antibacterial drugs, levofloxacin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Levofloxacin tablets, USP are indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Culture and susceptibility testing Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to l
16.1 Levofloxacin Tablets, USP Levofloxacin tablets, USP are supplied as 500 mg capsule-shaped, coated tablets. Levofloxacin tablets, USP are packaged in bottles and in unit-dose blister strips in the following configurations: 500 mg tablets are: peach coloured, capsule shaped, biconvex, debossed 'ML 63' on one side and plain on other side. Levofloxacin Tablets, USP should be stored at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86 °F) in well-closed containers. Levofloxacin Tablets are manufactured by Macleods Pharmaceutical Limited, Village Theda, Post Office Lodhimajra, Tehsil Nalagarh, District Solan, Himachal Pradesh – 174101, India.
Abbreviated New Drug Application
LEVOFLOXACIN- LEVOFLOXACIN TABLET, FILM COATED Proficient Rx LP ---------- MEDICATION GUIDE MEDICATION GUIDE Levofloxacin Tablets (LEE-voe-FLOX-a-sin) What is the most important information I should know about levofloxacin tablets? Levofloxacin tablets, a fluoroquinolone antibiotic, can cause serious side effects. Some of these serious side effects can happen at the same time and could result in death. If you have any of the following serious side effects while you take levofloxacin tablets, you should stop taking levofloxacin tablets immediately and get medical help right away. 1. Tendon rupture or swelling of the tendon (tendinitis). • Tendon problems can happen in people of all ages who take levofloxacin tablets. Tendons are tough cords of tissue that connect muscles to bones. Some tendon problems include: o Pain o swelling o tears and swelling of tendons including the back of the ankle (Achilles), shoulder, hand, or other tendon sites. • The risk of getting tendon problems while you take levofloxacin tablets is higher if you: o are over 60 years of age o are taking steroids (corticosteroids) o have had a kidney, heart or lung transplant. • Tendon problems can happen in people who do not have the above risk factors when they take levofloxacin tablets. • Other reasons that can increase your risk of tendon problems can include: o physical activity or exercise o kidney failure o tendon problems in the past, such as in people with rheumatoid arthritis (RA) • Stop taking levofloxacin tablets immediately and get medical help right away at the first sign of tendon pain, swelling or inflammation. Avoid exercise and using the affected area. • The most common area of pain and swelling is the Achilles tendon at the back of your ankle. This can also happen with other tendons. You may need a different antibiotic that is not a fluoroquinolone to treat your infection. • Tendon rupture can happen while you are taking or after you have finished taking levofloxacin tablets. Tendon ruptures can happen within hours Baca dokumen lengkap
LEVOFLOXACIN- LEVOFLOXACIN TABLET, FILM COATED PROFICIENT RX LP ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE LEVOFLOXACIN TABLETS, USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR LEVOFLOXACIN TABLETS, USP. LEVOFLOXACIN TABLET, USP FILM COATED FOR ORAL USE INITIAL U.S. APPROVAL: 1996 RECENT MAJOR CHANGES Warnings and Precautions • Peripheral Neuropathy (5.8) 07/2013 INDICATIONS AND USAGE Levofloxacin USP is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria (1, 12.4). • Pneumonia: nosocomial (1.1) and community acquired (1.2, 1.3) • Acute bacterial sinusitis (1.4) • Acute bacterial exacerbation of chronic bronchitis (1.5) • Skin and skin structure infections: complicated (1.6) and uncomplicated (1.7) • Chronic bacterial prostatitis (1.8) • Urinary tract infections: complicated (1.9, 1.10) and uncomplicated (1.12) • Acute pyelonephritis (1.11) • Inhalational anthrax, post-exposure (ERROR! HYPERLINK REFERENCE NOT VALID.) • Plague (ERROR! HYPERLINK REFERENCE NOT VALID.) DOSAGE AND ADMINISTRATION • TYPE OF INFECTION DOSE EVERY 24 HOURS DURATION (DAYS) Nosocomial Pneumonia (1.1) 750 mg 7–14 Community Acquired Pneumonia (1.2) 500 mg 7–14 Community Acquired Pneumonia (1.3) 750 mg 5 Acute Bacterial Sinusitis (1.4) 750 mg 5 500 mg 10-14 Acute Bacterial Exacerbation of Chronic Bronchitis (1.5) 500 mg 7 Complicated Skin and Skin Structure Infections (SSSI) (1.6) 750 mg 7-14 Uncomplicated SSSI (1.7) 500 mg 7-10 Chronic Bacterial Prostatitis (1.8) 500 mg 28 Complicated Urinary Tract Infection (1.9) or Acute Pyelonephritis (1.11) 750 mg 5 Complicated Urinary Tract Infection (1.10) or Acute Pyelonephritis (1.11) 250 mg 10 Uncomplicated Urinary Tract Infection (1.12) 250 mg 3 Inhalational Anthrax (Post- Exposure) (ERROR! HYPERLINK REFERENCE NOT VALID.) Adults and Pediatric Patients > 50 kg Pediatric Pa Baca dokumen lengkap